Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity
https://pixabay.com/en/baby-girl-sleep-child-toddler-1151351/

Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity

Orphan Drug designation is typically granted to drugs or biologics intended to treat, prevent, or diagnose rare diseases; in the United States, these are conditions affecting under 200,000 Americans. Drug…

Continue Reading Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity